GlassScriptPhysician profile
Frederick L Weber
NPI 1316995509
$33,817.81
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $4,650 · 2022: $6,271.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $30,582.82 | 2019-2022 | |
| Abbvie INC. | $1,266.96 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $483.57 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $374.68 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $124.79 | 2020-2022 | |
| Nestle Healthcare Nutrition INC. | $119.88 | 2021-2022 | |
| Braintree Laboratories, INC. | $117.55 | 2020-2022 | |
| Janssen Biotech, INC. | $96.85 | 2019-2022 | |
| Ardelyx, INC. | $80.37 | 2022 | |
| Qol Medical, LLC | $73.19 | 2022 | |
| Daiichi Sankyo INC. | $68.55 | 2019-2021 | |
| Pfizer INC. | $66.94 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $59.70 | 2022 | |
| Intercept Pharmaceuticals, INC. | $46.79 | 2020-2022 | |
| Shionogi INC | $46.04 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $37.87 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $34.35 | 2022 | |
| Genzyme Corporation | $32.72 | 2022 | |
| Shire North American Group INC | $18.44 | 2019 | |
| Sebela Pharmaceuticals INC. | $16.29 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.85 | 2021 | |
| Shield Therapeutics INC | $14.45 | 2022 | |
| Amgen INC. | $12.59 | 2020 | |
| Concordia Pharmaceuticals INC. | $11.30 | 2019 | |
| Olympus America INC. | $11.00 | 2019 | |
| Organon LLC | $5.27 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.